No, GLP-1 receptor agonists are not FDA-approved for rheumatoid arthritis treatment
We now have a breakthrough class of drugs that can achieve profound weight loss equivalent to bariatric surgery, along with the side benefits of reducing cardiovascular risk factors (hypertension and hyperlipidemia), improving glucose regulation, reversing fatty liver, and the many detrimental long-term effects of obesity such as osteoarthritis and various cancers
The titration schedule can be as follows (for example): Month 1: Women: 1.5 mg once weekly Men: 1.8 mg once weekly (Note: The standard starting dose is 2.5 mg weekly
Baek Y, Lee SE, Han K, Koh EH
Why is it that some people see results early and others take long before they can see it
Understanding mechanisms, optimal dosing, timing, and potential interactions requires hours of reading and learning